apomorphine has been researched along with Hallucinations in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (33.33) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 8 (53.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borgemeester, RWK; van Laar, T | 1 |
| Lees, AJ | 1 |
| Annic, A; Defebvre, L; Destée, A; Devos, D; Dujardin, K; Kreisler, A; Moreau, C; Mutez, E; Rambour, M; Salleron, J; Simonin, C | 1 |
| Borgemeester, RW; Drent, M; van Laar, T | 1 |
| Borgemeester, RW; Lees, AJ; van Laar, T | 1 |
| Drent, M; Postma, AG; van Laar, T | 1 |
| Kulisevsky, J; Martí, MJ | 1 |
| Carballo-Cordero, M; Giménez de Béjar, V | 1 |
| Brotchie, JM; Fox, SH; Gomez-Ramirez, J; Johnston, TH; Pires, D; Visanji, NP; Voon, V | 1 |
| Lecrubier, Y; Puech, AJ; Simon, P | 1 |
| Bjørndal, N; Christensson, E; Gerlach, J | 1 |
| Mellers, JD; Quinn, NP; Ron, MA | 1 |
| Angrist, B; Gershon, S; Shopsin, B; Thompson, H | 1 |
| Amitai, M; Dickhaut, HH; Hasenknopf, P | 1 |
| Entin, GM | 1 |
2 review(s) available for apomorphine and Hallucinations
| Article | Year |
|---|---|
Parkinson's disease, visual hallucinations and apomorphine: A review of the available evidence.
Topics: Animals; Apomorphine; Dopamine Agonists; Hallucinations; Humans; Parkinson Disease | 2016 |
[Candidate patient for treatment with continuous apomorphine infusion].
Topics: Aged; Antiparkinson Agents; Apomorphine; Clinical Trials as Topic; Cognition Disorders; Contraindications; Depression; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Hallucinations; Humans; Infusions, Intravenous; Middle Aged; Parkinson Disease; Patient Selection; Psychoses, Substance-Induced; Psychotic Disorders | 2012 |
1 trial(s) available for apomorphine and Hallucinations
| Article | Year |
|---|---|
Continuous subcutaneous infusion of apomorphine can be used safely in patients with Parkinson's disease and pre-existing visual hallucinations.
Topics: Aged; Analysis of Variance; Antiparkinson Agents; Apomorphine; Domperidone; Female; Hallucinations; Humans; Infusions, Subcutaneous; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Parkinson Disease; Prospective Studies; Severity of Illness Index | 2010 |
12 other study(ies) available for apomorphine and Hallucinations
| Article | Year |
|---|---|
Continuous subcutaneous apomorphine infusion in Parkinson's disease patients with cognitive dysfunction: A retrospective long-term follow-up study.
Topics: Aged; Antiparkinson Agents; Apomorphine; Cognitive Dysfunction; Cohort Studies; Dopamine Agonists; Female; Follow-Up Studies; Hallucinations; Humans; Hypotension, Orthostatic; Infusions, Subcutaneous; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Retrospective Studies | 2017 |
From Sgt. Pepper to Dreamachines: My Scientific Odyssey With William S. Burroughs.
Topics: Apomorphine; Banisteriopsis; Brain; Dopamine Agonists; Hallucinations; History, 20th Century; Humans; Light; Literature, Modern; Magnetic Resonance Imaging; Medicine in Literature; Parkinson Disease; Physicians; Psychotropic Drugs; United States | 2017 |
[Continuous subcutaneous infusion of apomorphine in Parkinson's disease: retrospective analysis of a series of 81 patients].
Topics: Adult; Aged; Antiparkinson Agents; Apomorphine; Dopamine Agonists; Drug Eruptions; Drug Evaluation; Female; Hallucinations; Humans; Infusions, Subcutaneous; Male; Middle Aged; Parkinson Disease; Patient Acceptance of Health Care; Quality of Life; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2014 |
Motor and non-motor outcomes of continuous apomorphine infusion in 125 Parkinson's disease patients.
Topics: Aged; Antiparkinson Agents; Apomorphine; Female; Hallucinations; Humans; Infusions, Subcutaneous; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Treatment Outcome | 2016 |
[Treatment of apomorphine infusion adverse effects: subcutaneous nodules and neuropsychiatric complications].
Topics: Adrenal Cortex Hormones; Antiparkinson Agents; Antipsychotic Agents; Apomorphine; Cholinesterase Inhibitors; Combined Modality Therapy; Disease Susceptibility; Dopamine Agonists; Drug Eruptions; Hallucinations; Humans; Infusions, Subcutaneous; Mental Disorders; Parkinson Disease; Physical Therapy Modalities; Psychomotor Agitation; Psychoses, Substance-Induced; Severity of Illness Index; Sleep Wake Disorders | 2012 |
Pharmacological characterization of psychosis-like behavior in the MPTP-lesioned nonhuman primate model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amantadine; Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Callithrix; Disability Evaluation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Female; Grooming; Hallucinations; Levodopa; Parkinsonian Disorders; Psychomotor Agitation; Psychotic Disorders; Statistics, Nonparametric; Stereotyped Behavior | 2006 |
Pharmacological classification of benzamides.
Topics: Animals; Antipsychotic Agents; Apomorphine; Benzamides; Brain; Dopamine Antagonists; Hallucinations; Humans; Receptors, Dopamine; Schizophrenia | 1984 |
Methylphenidate, apomorphine, THIP, and diazepam in monkeys: dopamine-GABA behavior related to psychoses and tardive dyskinesia.
Topics: Animals; Apomorphine; Chlorocebus aethiops; Diazepam; Dopamine; Drug Interactions; Dyskinesia, Drug-Induced; Female; gamma-Aminobutyric Acid; Hallucinations; Humans; Isoxazoles; Male; Methylphenidate; Motor Activity; Oxazoles; Psychoses, Substance-Induced | 1984 |
Psychotic and depressive symptoms in Parkinson's disease. A study of the growth hormone response to apomorphine.
Topics: Aged; Apomorphine; Depressive Disorder; Female; Growth Hormone; Hallucinations; Humans; Male; Middle Aged; Neurocognitive Disorders; Parkinson Disease; Receptors, Dopamine; Receptors, Serotonin; Reference Values | 1995 |
Clinical studies with dopamine-receptor stimulants.
Topics: Adult; Apomorphine; Blood Pressure; Dopamine; Female; Hallucinations; Humans; Male; Metoclopramide; Middle Aged; Piperazines; Piribedil; Receptors, Drug; Schizophrenia; Schizophrenia, Paranoid; Schizophrenic Psychology; Stimulation, Chemical; Vomiting | 1975 |
[Therapy of withdrawal symptoms in "fixers". (Drug abuse of adolescents by intravenous injection)].
Topics: Adolescent; Adult; Anxiety; Apomorphine; Female; Hallucinations; Humans; Male; Morphine Dependence; Psychotherapy; Substance Withdrawal Syndrome | 1972 |
[The clinical picture and therapy of alcoholic psychoses in old age].
Topics: Acute Disease; Apomorphine; Barbiturates; Cerebrovascular Disorders; Delirium; Delusions; Female; Hallucinations; Haloperidol; Humans; Male; Paranoid Disorders; Psychoses, Alcoholic; Tranquilizing Agents; Vitamins | 1970 |